Enhancing effect of bromovinyldeoxyuridine on antitumor activity of 5-fluorouracil and ftorafur against adenocarcinoma 755 in mice

This publication has 14 references indexed in Scilit:

• Potentiation of the chemotherapeutic action of tegafur against solid adenocarcinoma 755 by combination with l-cystine
  Zeitschrift für Krebsforschung und Klinische Onkologie, 1986
• Mechanism of potentiation of antitumor activity of 5-fluorouracil against adenocarcinoma 755 by L-cysteine
  Biochemical Pharmacology, 1986
• Inhibition of the degradation of thymine and 5-substituted uracil analogues by (E)-5-(2-bromovinyl)uracil in vivo
  Biochemical Pharmacology, 1985
• Synthesis and antiviral properties of 5-vinylpyrimidine nucleoside analogs
  Pharmacology & Therapeutics, 1984
• Regeneration of the antivirel drug(E)-5-(2-bromovinyl)-2′ -deoxyuridinein vivo
  Nucleic Acids Research, 1984
• The synthesis of the potent anti-herpes virus agent, E-5(2-bromovinyl)-2′-deoxyuridine and related compounds
  Tetrahedron Letters, 1979
• The clinical impact of screening and other experimental tumor studies
  Cancer Treatment Reviews, 1975
• Studies on the Fate of 1-(2-Tetrahydrofuryl)-5-fluorouracil (FT-207), a Carcinostatic Agent. III. Absorption, Distribution, Excretion and Metabolism after Rectal Administration of FT-207
  YAKUGAKU ZASSHI, 1975
• Results of treatment of malignant tumors with ftorafur
  Cancer, 1972
• Studies on fluorinated pyrimidines: VII—the degradative pathway
  Biochemical Pharmacology, 1959